Matrix metalloproteinases 2, 7, 8, 9 and their type 1 tissue inhibitor in serum of renal cancer patients: clinical and pathologic correlations

Matrix metalloproteinases 2, 7, 8, 9 and their type 1 tissue inhibitor in serum of renal cancer patients: clinical and pathologic correlations

Background: The cause of late diagnosis of renal cancer lies in its durable, almost asymptomatic course. Due to the use of antiangiogenic therapies much progress has been made in its treatment in recent years. Yet, many questions concerning the diagnosis, prognosis and prediction of the efficiency o...

Full description

Bibliographic Details
Main Authors:	E. S. Gershtein, V. V. Mushtenko, E. A. Korotkova, S. D. Bezhanova, A. A. Morozov, A. A. Alferov, I. A. Kazantseva, N. E. Kushlinskii
Format:	Article
Language:	Russian
Published:	MONIKI 2017-05-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	renal cancer matrix metalloproteinases 2, 7, 8, 9 tissue inhibitor of matrix metalloproteinases-1 serum diagnostic characteristics
Online Access:	https://www.almclinmed.ru/jour/article/view/520

Similar Items

Key VEGF signaling system components and matrix metalloproteinases in the diagnosis and prognosis of overall survival of patients with renal cell cancer
by: N. E. Kushlinskii, et al.
Published: (2020-07-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Clinical prospects of matrix metalloproteinases and their tissue inhibitors study in blood serum of patients with endometrial cancer and benign endometrial lesions
by: E. S. Gershtein, et al.
Published: (2017-08-01)

Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients
by: Ekaterina A. Korotkova, et al.
Published: (2023-05-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants
by: Rabia Gonul Sezer, et al.
Published: (2013-01-01)

Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study
by: Chao Yuan, et al.
Published: (2018-03-01)

Immunohistochemical expression of matrix metalloproteinase -9 in invasive meningioma
by: Samar U. Hasan*, et al.
Published: (2021-07-01)

Asthma remodeling: The pathogenic role of matrix metalloproteinase-9
by: Amgad A. Farhat, et al.
Published: (2014-10-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Matrix metalloproteinase-9, its inhibitor-1 and interleukines in experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-12-01)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
by: Shinji Takai, et al.
Published: (2022-10-01)

Diagnostic value of matrix metalloproteinase-9 in the course of osteoarthritis in young persons with excessive body weight and obesity
by: A. Litvynova, et al.
Published: (2022-06-01)

Eotaxin-induced expression of membrane type 1 matrix metalloproteinase mRNA in human eosinophils
by: Izumi Kurosaki, et al.
Published: (2000-01-01)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
by: Ya-Tang Chiang, et al.
Published: (2023-01-01)

Classification, regulation of activity, and genetic polymorphism of matrix metalloproteinases in health and disease
by: A. S. Shadrina, et al.
Published: (2017-08-01)

Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies
by: Mohsen Hanifeh, et al.
Published: (2018-03-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
by: Hao Huang
Published: (2018-09-01)

Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
by: Ling-Feng Wang, et al.
Published: (2013-01-01)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019-01-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Gelatinases A and B activities in the serum of patients with various coronary artery disease stages
by: Radenković Sandra, et al.
Published: (2010-01-01)

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017-05-01)

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017-05-01)

Assessment of the Relationship Between Matrix Metalloproteinase-9 Promoter Gene Polymorphism and Chronic Periodontitis
by: Hiroj Bagde, et al.
Published: (2021-11-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Matrix metalloproteinase 7 expression in ampullary carcinoma
by: Niraj Kumari, et al.
Published: (2015-01-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Neuroprotective Effects of Chlorogenic Acid in a Mouse Model of Intracerebral Hemorrhage Associated with Reduced Extracellular Matrix Metalloproteinase Inducer
by: Yang Liu, et al.
Published: (2022-07-01)

Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
by: Duda Izabela, et al.
Published: (2020-03-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)